Crystallization and characterization of cocrystals of piroxicam and 2,5-dihydroxybenzoic acid
- 1 May 2015
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in CrystEngComm
- Vol. 17 (28) , 5299-5306
Abstract
A cocrystal of piroxicam (PRX) and 2,5-dihydroxybenzoic acid (HBA), PRX–HBA, and an acetone (ACT) solvate of the cocrystal, PRX–HBA–ACT, were crystallized on a microfluidic platform via solvent evaporation. The inclusion of ACT was found serendipitously, with the ACT probably being introduced into the crystallization system as an impurity in HBA. The crystal structures of PRX–HBA and PRX–HBA–ACT obtained by X-ray diffraction both exhibit the P21/c space group. Bulk quantities of the cocrystals were synthesized using a slurry method and their physical properties were characterized with thermogravimetric analysis and differential scanning calorimetry. Additionally, the phase behavior of PRX–HBA–ACT during desolvation was monitored with powder X-ray diffraction. The powder diffraction of PRX–HBA–ACT after complete desolvation has the same peak positions as the PRX–HBA, suggesting that PRX–HBA–ACT re-arranges to the structure of PRX–HBA.Keywords
Funding Information
- AbbVie
- Division of Graduate Education (DGE-1144245)
This publication has 22 references indexed in Scilit:
- Solubility Advantage of Amorphous Drugs and Pharmaceutical CocrystalsCrystal Growth & Design, 2011
- FINDING SOLUTIONS2010
- Cocrystals of Piroxicam with Carboxylic AcidsCrystal Growth & Design, 2007
- Development of a pharmaceutical cocrystal of a monophosphate salt with phosphoric acidChemical Communications, 2006
- Physical stability enhancement of theophylline via cocrystallizationInternational Journal of Pharmaceutics, 2006
- Phase Solubility Diagrams of Cocrystals Are Explained by Solubility Product and Solution ComplexationCrystal Growth & Design, 2005
- Pharmaceutical Cocrystallization: Engineering a Remedy for Caffeine HydrationCrystal Growth & Design, 2005
- Crystal Engineering Approach To Forming Cocrystals of Amine Hydrochlorides with Organic Acids. Molecular Complexes of Fluoxetine Hydrochloride with Benzoic, Succinic, and Fumaric AcidsJournal of the American Chemical Society, 2004
- Crystal Engineering of Novel Cocrystals of a Triazole Drug with 1,4-Dicarboxylic AcidsJournal of the American Chemical Society, 2003
- A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo BioavailabilityPharmaceutical Research, 1995